Genomic diversity in low-risk disease: present and future

Vidit Sharma; R. Jeffrey Karnes

doi:10.1038/s41585-018-0073-2

Genomic diversity in low-risk disease: present and future

Vidit Sharma, R. Jeffrey Karnes

Urology

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

New data have confirmed the genomic diversity of low-risk prostate cancer. Improved understanding of the heterogeneity of this disease has implications for disease management and has the potential to change treatment for patients in the future.

Original language	English (US)
Pages (from-to)	594-596
Number of pages	3
Journal	Nature Reviews Urology
Volume	15
Issue number	10
DOIs	https://doi.org/10.1038/s41585-018-0073-2
State	Published - Oct 1 2018

ASJC Scopus subject areas

Urology

Access to Document

10.1038/s41585-018-0073-2

Cite this

@article{d2f34b15e3394dcf99f157cda731ca8d,

title = "Genomic diversity in low-risk disease: present and future",

abstract = "New data have confirmed the genomic diversity of low-risk prostate cancer. Improved understanding of the heterogeneity of this disease has implications for disease management and has the potential to change treatment for patients in the future.",

author = "Vidit Sharma and Karnes, {R. Jeffrey}",

note = "Publisher Copyright: {\textcopyright} 2018, Springer Nature Limited.",

year = "2018",

month = oct,

day = "1",

doi = "10.1038/s41585-018-0073-2",

language = "English (US)",

volume = "15",

pages = "594--596",

journal = "Nature Reviews Urology",

issn = "1759-4812",

publisher = "Nature Publishing Group",

number = "10",

}

TY - JOUR

T1 - Genomic diversity in low-risk disease

T2 - present and future

AU - Sharma, Vidit

AU - Karnes, R. Jeffrey

PY - 2018/10/1

Y1 - 2018/10/1

N2 - New data have confirmed the genomic diversity of low-risk prostate cancer. Improved understanding of the heterogeneity of this disease has implications for disease management and has the potential to change treatment for patients in the future.

AB - New data have confirmed the genomic diversity of low-risk prostate cancer. Improved understanding of the heterogeneity of this disease has implications for disease management and has the potential to change treatment for patients in the future.

UR - http://www.scopus.com/inward/record.url?scp=85052594148&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052594148&partnerID=8YFLogxK

U2 - 10.1038/s41585-018-0073-2

DO - 10.1038/s41585-018-0073-2

M3 - Comment/debate

C2 - 30097623

AN - SCOPUS:85052594148

SN - 1759-4812

VL - 15

SP - 594

EP - 596

JO - Nature Reviews Urology

JF - Nature Reviews Urology

IS - 10

ER -

Genomic diversity in low-risk disease: present and future

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this